LexaGene (OTCQB:LXXGF) (TSX-V:LXG) Raises C$5 Million To Advance Development of Microfluidic Technology

LexaGene’s technology was originally designed for pathogen detection across very large markets – I’m thrilled to report that we are working to expand our technology’s capability to include cancer diagnostics and Next Generation Sequencing

Submitted June 26, 2018 at 11:07AM by TrueInvestor https://ift.tt/2lAlN2D